Literature DB >> 34101796

Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021.

A P Porsteinsson1, R S Isaacson, S Knox, M N Sabbagh, I Rubino.   

Abstract

Alzheimer's disease is a progressive, irreversible neurodegenerative disease impacting cognition, function, and behavior. Alzheimer's disease progresses along a continuum from preclinical disease, to mild cognitive and/or behavioral impairment and then Alzheimer's disease dementia. Recently, clinicians have been encouraged to diagnose Alzheimer's earlier, before patients have progressed to Alzheimer's disease dementia. The early and accurate detection of Alzheimer's disease-associated symptoms and underlying disease pathology by clinicians is fundamental for the screening, diagnosis, and subsequent management of Alzheimer's disease patients. It also enables patients and their caregivers to plan for the future and make appropriate lifestyle changes that could help maintain their quality of life for longer. Unfortunately, detecting early-stage Alzheimer's disease in clinical practice can be challenging and is hindered by several barriers including constraints on clinicians' time, difficulty accurately diagnosing Alzheimer's pathology, and that patients and healthcare providers often dismiss symptoms as part of the normal aging process. As the prevalence of this disease continues to grow, the current model for Alzheimer's disease diagnosis and patient management will need to evolve to integrate care across clinical disciplines and the disease continuum, beginning with primary care. This review summarizes the importance of establishing an early diagnosis of Alzheimer's disease, related practical 'how-to' guidance and considerations, and tools that can be used by healthcare providers throughout the diagnostic journey.

Entities:  

Keywords:  Alzheimer’s disease; diagnostic work-up; early diagnosis

Year:  2021        PMID: 34101796     DOI: 10.14283/jpad.2021.23

Source DB:  PubMed          Journal:  J Prev Alzheimers Dis        ISSN: 2274-5807


  10 in total

Review 1.  Hypertension and cognitive function: a review of life-course factors and disparities.

Authors:  Ileana De Anda-Duran; Sara G Woltz; Caryn N Bell; Lydia A Bazzano
Journal:  Curr Opin Cardiol       Date:  2022-07-01       Impact factor: 2.108

2.  Large Margin and Local Structure Preservation Sparse Representation Classifier for Alzheimer's Magnetic Resonance Imaging Classification.

Authors:  Runmin Liu; Guangjun Li; Ming Gao; Weiwei Cai; Xin Ning
Journal:  Front Aging Neurosci       Date:  2022-05-25       Impact factor: 5.702

3.  In-depth insights into Alzheimer's disease by using explainable machine learning approach.

Authors:  Bojan Bogdanovic; Tome Eftimov; Monika Simjanoska
Journal:  Sci Rep       Date:  2022-04-20       Impact factor: 4.996

4.  Anodal transcranial direct current stimulation alleviates cognitive impairment in an APP/PS1 model of Alzheimer's disease in the preclinical stage.

Authors:  Yin-Pei Luo; Zhi Liu; Cong Wang; Xiu-Fang Yang; Xiao-Ying Wu; Xue-Long Tian; Hui-Zhong Wen
Journal:  Neural Regen Res       Date:  2022-10       Impact factor: 6.058

5.  Clinical Staging of Alzheimer's Disease: Concordance of Subjective and Objective Assessments in the Veteran's Affairs Healthcare System.

Authors:  Peter Morin; Mingfei Li; Ying Wang; Byron J Aguilar; Dan Berlowitz; Amir Abbas Tahami Monfared; Michael Irizarry; Quanwu Zhang; Weiming Xia
Journal:  Neurol Ther       Date:  2022-07-01

6.  Alzheimer's Disease Blood Biomarkers Associated With Neuroinflammation as Therapeutic Targets for Early Personalized Intervention.

Authors:  Sher Li Oh; Meikun Zhou; Eunice W M Chin; Gautami Amarnath; Chee Hoe Cheah; Kok Pin Ng; Nagaendran Kandiah; Eyleen L K Goh; Keng-Hwee Chiam
Journal:  Front Digit Health       Date:  2022-07-11

7.  Why don't people with MCI approach memory clinics? The role of awareness in medical help-seeking.

Authors:  Ariela Gigi; Merav Papirovitz
Journal:  Front Neurol       Date:  2022-08-24       Impact factor: 4.086

8.  Conditions required to ensure successful detection and management of mild cognitive impairment in primary care: A Delphi consultation study in China.

Authors:  Yuan Lu; Chaojie Liu; Dehua Yu; Yvonne Wells
Journal:  Front Public Health       Date:  2022-09-23

9.  Research status, hotspots and trends of acupuncture and moxibustion in the treatment of Alzheimer's disease: A bibliometric analysis.

Authors:  Jinhuan Yue; Xiao-Ling Li; Rui-Xue Gao; Qinhong Zhang; Ang Li; Wei-Wei Zhao; Yan Li; Shu-Lin Li
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

10.  Syndecan-3 as a Novel Biomarker in Alzheimer's Disease.

Authors:  Anett Hudák; Annamária Letoha; Csaba Vizler; Tamás Letoha
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.